Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Jul 26, 2019
Palo Alto psychiatrist Rameen Ghorieshi joins Weekly journalists to discuss the potential of ketamine to treat severely depressed patients, who have seen remarkable results. Topics discussed: Background on ketamine (0:09); Esketamine, a ketamine nasal spray approved by the FDA (5:08); treatment process (9:03); risks of ketamine (13:38); and future of ketamine (18:42).